PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.47%
Revenue growth above 1.5x ON's 3.94%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
13.31%
Gross profit growth above 1.5x ON's 7.51%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
37.52%
EBIT growth 1.25-1.5x ON's 32.22%. Bruce Berkowitz would verify if strategic initiatives are driving this edge.
-6.84%
Negative operating income growth while ON is at 32.22%. Joel Greenblatt would press for urgent turnaround measures.
-4.70%
Negative net income growth while ON stands at 8.60%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-5.08%
Negative EPS growth while ON is at 9.09%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-3.45%
Negative diluted EPS growth while ON is at 0.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.63%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.54%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
0.31%
Dividend growth of 0.31% while ON is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
70.77%
OCF growth above 1.5x ON's 8.51%. David Dodd would confirm a clear edge in underlying cash generation.
77.99%
FCF growth above 1.5x ON's 18.99%. David Dodd would verify if the firm’s strategic investments yield superior returns.
100.90%
10Y revenue/share CAGR above 1.5x ON's 7.93%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
13.95%
5Y revenue/share CAGR above 1.5x ON's 9.23%. David Dodd would look for consistent product or market expansions fueling outperformance.
-6.30%
Negative 3Y CAGR while ON stands at 14.40%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
254.02%
10Y OCF/share CAGR under 50% of ON's 1894.22%. Michael Burry would worry about a persistent underperformance in cash creation.
30.17%
Positive OCF/share growth while ON is negative. John Neff might see a comparative advantage in operational cash viability.
-5.66%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
120.73%
Net income/share CAGR at 50-75% of ON's 226.96%. Martin Whitman might question if the firm’s product or cost base lags behind.
32.93%
Positive 5Y CAGR while ON is negative. John Neff might view this as a strong mid-term relative advantage.
-20.90%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
51.69%
Below 50% of ON's 197.21%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
30.26%
5Y equity/share CAGR 1.25-1.5x ON's 20.26%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
19.84%
3Y equity/share CAGR above 1.5x ON's 10.21%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
1205.79%
Dividend/share CAGR of 1205.79% while ON is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
179.73%
Dividend/share CAGR of 179.73% while ON is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
132.68%
3Y dividend/share CAGR of 132.68% while ON is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
2.21%
Our AR growth while ON is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
0.35%
Inventory shrinking or stable vs. ON's 4.57%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
-0.79%
Negative asset growth while ON invests at 0.23%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
0.48%
Under 50% of ON's 2.80%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-0.08%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-5.40%
Our R&D shrinks while ON invests at 1.08%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-1.27%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.